| Articles Reviewed |
| 1: | Weiming Ouyang et al. Benzo[a]pyrene diol-epoxide (B[a]PDE) upregulates COX-2 expression through MAPKs/AP-1 and IKKbeta/NF-kappaB in mouse epidermal Cl41 cells. 2007 |
| 2: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 3: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 4: | Jinyi Shao et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005 |
| 5: | Lodewijk A A Brosens et al. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. 2005 |
| 6: | Yunfei Ding et al. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. 2005 |
| 7: | Ho Kim et al. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. 2005 |
| 8: | Chung-Yau Lo et al. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma. 2005 |
| 9: | Katsuhiko Nosho et al. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. 2005 |
| 10: | Anne Haguenauer et al. A new renal mitochondrial carrier, KMCP1, is up-regulated during tubular cell regeneration and induction of antioxidant enzymes. 2005 |
| 11: | Nan Sang et al. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. 2005 |
| 12: | Asim K Mandal et al. Uteroglobin inhibits prostaglandin F2alpha receptor-mediated expression of genes critical for the production of pro-inflammatory lipid mediators. 2005 |
| 13: | Catherine E Trebino et al. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. 2005 |
| 14: | Makoto Murakami et al. Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2). 2005 |
| 15: | Gi Jin Kim et al. Expression of bone morphogenetic protein 2 in normal spontaneous labor at term, preterm labor, and preterm premature rupture of membranes. 2005 |
| 16: | Shigeyuki Uno et al. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. 2004 |
| 17: | Karina L Therland et al. Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors. 2004 |
| 18: | Martin Kömhoff et al. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. 2004 |
| 19: | Aitor G Granja et al. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. 2004 |
| 20: | Naveen Babbar et al. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. 2003 |
| 21: | Marina Premyslova et al. Differential expression and regulation of microsomal prostaglandin E(2) synthase in human fetal membranes and placenta with infection and in cultured trophoblast cells. 2003 |
| 22: | Nico Hendrickx et al. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. 2003 |
| 23: | Michael D Southall et al. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. 2003 |
| 24: | Dilprit Bagga et al. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. 2003 |
| 25: | Abhijit G Banerjee et al. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. 2003 |
| 26: | Qinghua Zeng et al. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression. 2002 |
| 27: | Xiaojuan Yan et al. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. 2002 |
| 28: | Toshiro Niki et al. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. 2002 |
| 29: | Zhuo-Wei Hu et al. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. 2002 |
| 30: | Ming Li et al. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. 2002 |
| 31: | Ying Zhu et al. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins. 2002 |
| 32: | Ruba S Deeb et al. Tyrosine nitration in prostaglandin H(2) synthase. 2002 |
| 33: | Rui Han et al. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. 2002 |
| 34: | Toru Asano et al. Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. 2002 |